HIV Funding Impacts Global health funding · LMIC Download the panel

Home  /  Eastern and Southern Africa  /  ERI

Eritrea

Eritrea appears only through international and donor bodies that compile figures across many countries, and no figures for the country are read directly from a national publisher. The assessment of national sources, country by country, is set out on the Methods page.

12,000
People living with HIV, 2025
WHO Global Health Observatory
75.0%
On antiretroviral treatment, 2025
WHO Global Health Observatory
$50k
United States HIV disbursements, 2013
OECD Creditor Reporting System
$2.0m
External HIV financing, all donors, 2024
OECD Creditor Reporting System
External HIV financing
OECD CRS · ForeignAssistance.gov
$0$10m$20m20022005200820112014201720202023$2.0m$50k$2.0m$50k
  • All donors
  • United States, OECD record
  • The Global Fund
  • United States, self-reported
YearAll donorsUnited States, OECD recordThe Global FundUnited States, self-reported
2002 $3.2m — — —
2003 $4.0m — — $1.7m
2004 $11.1m $2.5m $3.7m $4.1m
2005 $13.0m $3.9m $3.2m $4.6m
2006 $8.8m $1.5m $4.8m $1.9m
2007 $9.5m $38k $5.1m $76k
2008 $16.0m — $10.5m $1k
2009 $15.7m — $12.4m —
2010 $19.5m — $16.6m —
2011 $8.3m $320 $6.9m —
2012 $18.1m $100k $17.6m $100k
2013 $11.7m $50k $11.1m $50k
2014 $19.2m — $18.9m —
2015 $3.8m — $3.2m —
2016 $9.0m — $8.7m —
2017 $7.4m — $7.4m —
2018 $10.3m — $10.3m —
2019 $6.7m — $6.7m —
2020 $2.8m — $2.7m —
2021 $5.4m — $5.4m —
2022 $7.2m — $7.2m —
2023 $11.3m — $11.3m —
2024 $2.0m — $2.0m —

23 rows, as drawn above. Values are rounded for display, and the download gives the unrounded values.

Disbursements reported for the country. The OECD record and the United States self-reported record are drawn separately. The two records cover the same United States disbursements, but the OECD record is filed by calendar year and the self-reported record by United States fiscal year.

People living with HIV and people on treatment
UNAIDS AIDSinfo
020k40k20002003200620092012201520182021202412,0008,900
  • People living with HIV
  • People on treatment
YearPeople living with HIVPeople living with HIV (lower)People living with HIV (upper)People on treatment
2000 28,000 21,000 37,000 —
2001 28,000 21,000 37,000 —
2002 27,000 20,000 35,000 —
2003 27,000 21,000 35,000 —
2004 26,000 20,000 33,000 —
2005 24,000 19,000 30,000 —
2006 22,000 17,000 27,000 —
2007 21,000 16,000 26,000 —
2008 20,000 16,000 25,000 —
2009 19,000 15,000 23,000 —
2010 18,000 14,000 22,000 4,700
2011 17,000 14,000 21,000 5,600
2012 17,000 13,000 20,000 6,400
2013 16,000 12,000 19,000 7,100
2014 15,000 12,000 18,000 7,900
2015 14,000 12,000 17,000 8,400
2016 14,000 11,000 17,000 8,700
2017 13,000 11,000 16,000 8,800
2018 13,000 11,000 16,000 8,900
2019 13,000 11,000 16,000 8,800
2020 13,000 10,000 15,000 9,100
2021 13,000 10,000 15,000 8,800
2022 13,000 10,000 15,000 8,800
2023 12,000 10,000 15,000 8,900
2024 12,000 10,000 15,000 8,900

25 rows, as drawn above. Values are rounded for display, and the download gives the unrounded values.

Modelled estimates. The shaded area is the published uncertainty interval around the number of people living with HIV, because a single estimate without the interval would overstate the precision of the model.

The treatment cascade
UNAIDS AIDSinfo
20%40%60%80%2010201220142016201820202022202479.0%72.0%69.0%
  • Diagnosed
  • On treatment
  • Virally suppressed
YearDiagnosedOn treatmentVirally suppressed
2010 44.0% 26.0% —
2011 49.0% 32.0% —
2012 53.0% 38.0% —
2013 57.0% 45.0% —
2014 62.0% 52.0% —
2015 66.0% 59.0% —
2016 70.0% 63.0% —
2017 72.0% 65.0% —
2018 75.0% 67.0% 52.0%
2019 76.0% 68.0% 58.0%
2020 77.0% 71.0% 63.0%
2021 78.0% 69.0% 60.0%
2022 78.0% 70.0% 63.0%
2023 79.0% 71.0% 67.0%
2024 79.0% 72.0% 69.0%

15 rows, as drawn above. Values are rounded for display, and the download gives the unrounded values.

Every line is a percentage of all people living with HIV, so the three lines share a denominator and can be compared directly. Viral suppression in the figure is the share of all people living with HIV who are virally suppressed, and not the narrower third 95 target, which counts only people on treatment.

Sources of the figures for Eritrea

2,760 rows

SourceTypeRowsIndicators YearsRead fromRetrieved
UNICEF HIV/AIDS dataset Modelled estimate 1,344 3 2010–2025 sdmx.data.unicef.org 2026-10-20
UNAIDS AIDSinfo Modelled estimate 724 28 2000–2024 aidsinfo.unaids.org 2026-10-20
WHO Global Health Observatory Modelled estimate 213 10 2000–2025 ghoapi.azureedge.net 2026-10-12
WHO Global Tuberculosis Programme Programme record 154 17 2000–2025 extranet.who.int 2026-10-16
Global Fund Data Service Programme record 80 10 2017–2025 fetch.theglobalfund.org 2026-10-12
OECD Creditor Reporting System Expenditure account 51 3 2002–2024 sdmx.oecd.org 2026-10-12
World Bank Open Data Modelled estimate 51 2 2000–2025 api.worldbank.org 2026-10-12
IATI, through d-portal Expenditure account 50 3 2000–2026 d-portal.org 2026-10-12
UNAIDS Global AIDS Monitoring expenditure database Expenditure account 30 9 2018–2021 hivfinancial.unaids.org 2026-10-12
WHO HIV testing services dashboard Programme record 29 4 2018–2023 eic-database-290813.ew.r.appspot.com 2026-10-14
ForeignAssistance.gov Expenditure account 20 3 2003–2013 foreignassistance.gov 2026-10-29
UNAIDS Data 2025 country databook Modelled estimate 10 2 2018–2024 aidsinfo.unaids.org 2026-10-15
Global Fund allocations Expenditure account 4 1 2017–2026 fetch.theglobalfund.org 2026-10-12

Indicators held

65 of 150

IndicatorDomainUnitRows YearsSourcesMost recent value
Actual expenditure on collaborative TB/HIV activities Financing USD 7 2018–2024 WHO Global Tuberculosis Programme $11k (2024)
Budget required for collaborative TB/HIV activities Financing USD 8 2018–2025 WHO Global Tuberculosis Programme $65k (2025)
Country-reported HIV expenditure, all sources Financing USD 8 2018–2021 UNAIDS AIDSinfo, UNAIDS Global AIDS Monitoring expenditure database $3.7m (2021)
Domestic funding received by the national TB programme Financing USD 3 2021–2024 WHO Global Tuberculosis Programme $0 (2024)
Expected Global Fund funding for the national TB programme Financing USD 8 2018–2025 WHO Global Tuberculosis Programme $1.7m (2025)
Expected USAID funding for the national TB programme Financing USD 5 2018–2025 WHO Global Tuberculosis Programme $0 (2025)
Expected domestic funding for the national TB programme Financing USD 4 2018–2025 WHO Global Tuberculosis Programme $0 (2025)
Expected funding for collaborative TB/HIV activities Financing USD 8 2018–2025 WHO Global Tuberculosis Programme $24k (2025)
External HIV financing (all donors, ODA) Financing USD 23 2002–2024 OECD Creditor Reporting System $2.0m (2024)
External HIV financing from governments other than the United States (IATI) Financing USD 12 2000–2025 IATI, through d-portal $0 (2025)
External HIV financing from multilateral bodies other than the Global Fund (IATI) Financing USD 15 2012–2026 IATI, through d-portal $241k (2026)
External HIV financing from the United States (ODA) Financing USD 15 2003–2013 ForeignAssistance.gov, OECD Creditor Reporting System $50k (2013)
Funding received for collaborative TB/HIV activities Financing USD 7 2018–2024 WHO Global Tuberculosis Programme $25k (2024)
Global Fund HIV allocation for a whole three-year cycle, not an annual figure Financing USD per three-year allocation cycle 4 2017–2026 Global Fund allocations 17,088,897 (2026)
Global Fund HIV disbursements to the country Financing USD 48 2004–2026 IATI, through d-portal, OECD Creditor Reporting System, UNAIDS Global AIDS Monitoring expenditure database $583k (2026)
Global Fund funding received by the national TB programme Financing USD 8 2017–2024 WHO Global Tuberculosis Programme $1.7m (2024)
HIV spending on TB/HIV co-infection Financing USD 1 2021 UNAIDS Global AIDS Monitoring expenditure database $15k (2021)
HIV spending on critical enablers Financing USD 1 2021 UNAIDS Global AIDS Monitoring expenditure database $61k (2021)
HIV spending on governance and sustainability Financing USD 4 2018–2021 UNAIDS Global AIDS Monitoring expenditure database $805k (2021)
HIV spending on prevention Financing USD 4 2018–2021 UNAIDS Global AIDS Monitoring expenditure database $469k (2021)
HIV spending on prevention of vertical transmission Financing USD 4 2018–2021 UNAIDS Global AIDS Monitoring expenditure database $185k (2021)
HIV spending on treatment, care and support Financing USD 4 2018–2021 UNAIDS Global AIDS Monitoring expenditure database $1.5m (2021)
International HIV expenditure (country-reported) Financing USD 8 2018–2021 UNAIDS Data 2025 country databook, UNAIDS Global AIDS Monitoring expenditure database $3.7m (2021)
US HIV disbursements managed by USAID Financing USD 6 2003–2008 ForeignAssistance.gov $0 (2008)
US HIV disbursements managed by other US agencies Financing USD 6 2005–2013 ForeignAssistance.gov $50k (2013)
USAID funding received by the national TB programme Financing USD 5 2017–2024 WHO Global Tuberculosis Programme $0 (2024)
% of ALL PLHIV who are virally suppressed Treatment cascade percent 14 2018–2024 UNAIDS AIDSinfo, WHO Global Health Observatory 71.0% (2024)
% of PLHIV on ART (second 95, PLHIV base) Treatment cascade percent 67 2000–2025 UNAIDS AIDSinfo, WHO Global Health Observatory 75.0% (2025)
% of PLHIV who have been diagnosed (first 95) Treatment cascade percent 26 2010–2025 UNAIDS AIDSinfo, WHO Global Health Observatory 82.0% (2025)
% of estimated HIV-positive incident TB cases on TB treatment and ART Treatment cascade percent 13 2012–2024 UNAIDS AIDSinfo 42.8% (2024)
% of people currently enrolled in HIV treatment started on TB preventive therapy Treatment cascade percent 3 2018–2023 UNAIDS AIDSinfo 1.8% (2023)
% of people newly enrolled in HIV treatment diagnosed with TB disease Treatment cascade percent 9 2013–2023 UNAIDS AIDSinfo 5.7% (2023)
% of people newly enrolled in HIV treatment started on TB preventive therapy Treatment cascade percent 5 2017–2023 UNAIDS AIDSinfo 71.3% (2023)
% of people on ART who are virally suppressed (third 95) Treatment cascade percent 7 2018–2024 WHO Global Health Observatory 96.0% (2024)
% of returned HIV test results that were positive Treatment cascade percent 17 2018–2023 UNAIDS AIDSinfo, WHO Global Health Observatory, WHO HIV testing services dashboard 0.1% (2023)
HIV self-test kits distributed Treatment cascade count 1 2023 WHO HIV testing services dashboard 300 (2023)
HIV tests performed at a health facility Treatment cascade count 4 2018–2023 WHO HIV testing services dashboard 259,760 (2023)
HIV tests performed with the result returned to the person Treatment cascade count 25 2017–2024 Global Fund Data Service, UNAIDS AIDSinfo, WHO Global Health Observatory, WHO HIV testing services dashboard 6,127 (2024)
HIV-exposed infants tested within two months of birth Treatment cascade percent 11 2013–2023 UNAIDS AIDSinfo 64.0% (2023)
HIV-positive TB patients started or continued on ART Treatment cascade count 19 2015–2025 Global Fund Data Service, WHO Global Tuberculosis Programme 32 (2025)
Key-population people tested for HIV (count over the period) Treatment cascade count 9 2017–2025 Global Fund Data Service By population group, sex or age only, to 2025
New HIV diagnoses with a CD4 count below 200 Treatment cascade percent 4 2017–2020 UNAIDS AIDSinfo 38.0% (2020)
Number of people on ART (PEPFAR MER TX_CURR) Treatment cascade count 78 2000–2025 Global Fund Data Service, UNAIDS AIDSinfo, WHO Global Health Observatory, WHO Global Tuberculosis Programme 8,964 (2025)
PMTCT ART coverage among pregnant women with HIV Treatment cascade percent 1 2024 UNAIDS AIDSinfo 97.0% (2024)
People living with HIV in care screened for TB Treatment cascade count 9 2017–2025 Global Fund Data Service 192 (2025)
People living with HIV on ART who started TB preventive therapy Treatment cascade count 9 2017–2025 Global Fund Data Service 138 (2025)
People newly enrolled on ART during the year Treatment cascade count 11 2013–2025 Global Fund Data Service, WHO Global Tuberculosis Programme 192 (2025)
Pregnant women tested for HIV in antenatal care Treatment cascade percent 7 2018–2024 UNAIDS AIDSinfo 98.0% (2024)
Pregnant women with HIV who received ARVs for PMTCT Treatment cascade count 10 2017–2025 Global Fund Data Service, UNAIDS AIDSinfo 95 (2025)
TB patients recorded as HIV-positive Treatment cascade count 10 2015–2024 WHO Global Tuberculosis Programme 41 (2024)
TB patients with an HIV test result recorded Treatment cascade count 19 2015–2025 Global Fund Data Service, WHO Global Tuberculosis Programme 2,023 (2025)
AIDS-related deaths Epidemic estimates count 681 2000–2025 UNAIDS AIDSinfo, UNICEF HIV/AIDS dataset, WHO Global Health Observatory 500 (2025)
Deaths from TB among people living with HIV Epidemic estimates count 50 2000–2024 UNAIDS AIDSinfo, WHO Global Tuberculosis Programme 46 (2024)
HIV prevalence among a key population Epidemic estimates percent 2 2024 UNAIDS AIDSinfo By population group, sex or age only, to 2024
HIV prevalence, ages 15-49 Epidemic estimates percent 50 2000–2024 UNAIDS AIDSinfo, World Bank Open Data 0.4% (2024)
Incident TB cases among people living with HIV Epidemic estimates count 50 2000–2024 UNAIDS AIDSinfo, WHO Global Tuberculosis Programme 96 (2024)
New HIV infections Epidemic estimates count 585 2000–2025 UNAIDS AIDSinfo, UNICEF HIV/AIDS dataset, WHO Global Health Observatory 500 (2025)
People living with HIV Epidemic estimates count 687 2000–2025 UNAIDS AIDSinfo, UNAIDS Data 2025 country databook, UNICEF HIV/AIDS dataset, WHO Global Health Observatory 12,000 (2025)
Key-population people reached by outreach (count over the period) Prevention and outreach count 7 2017–2025 Global Fund Data Service By population group, sex or age only, to 2025
Male condoms distributed in a year Prevention and outreach count 3 2019–2023 UNAIDS AIDSinfo 4,962,337 (2023)
People receiving PrEP Prevention and outreach count 2 2021–2022 UNAIDS AIDSinfo 100 (2022)
Estimated pregnant women with HIV needing ARVs for PMTCT Population denominators count 1 2024 UNAIDS AIDSinfo 200 (2024)
Estimated size of a key population Population denominators count 1 2024 UNAIDS AIDSinfo By population group, sex or age only, to 2024
Total population Population denominators count 26 2000–2025 World Bank Open Data 3,607,003 (2025)
Share of HIV-exposed infants who acquire HIV — percent 1 2024 UNAIDS AIDSinfo 19.0% (2024)

Every row shown on the Eritrea page is in the panel download, with the source URL and the retrieval date of the row attached. See Data.